|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
26.950 -2.200 (-7.547%) Ranking Overview
Ranking based on 5 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | -601.00 RMB (cts) | |
| Net Profit | -1,482.73 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | -269.00 | -109.00 | 0 | -- | -227.00 | -395.00 |
| 2025 | -19.00 | -8.00 | 0 | -- | 83.00 | -90.00 |
| 2026 | 240.50 | 97.45 | 0 | -- | 402.00 | 103.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | -227.00 | -92.00 | -- | MORGAN STANLEY | Overweight | 38.00 | 02/09/2024 | |
| 2024 | -269.00 | -109.00 | -- | UBS | Buy | 32.10 | 01/11/2024 | |
| 2024 | -243.00 | -98.00 | -- | CITIC SEC | Buy | 32.00 | 04/11/2024 | |
| 2024 | -395.00 | -160.00 | -- | CICC | OutPerform | 24.72 | 31/08/2024 | |
| 2024 | -297.00 | -120.00 | -- | BANK OF AMERICA | Buy | 22.60 | 30/08/2024 | |
| 2025 | 83.00 | 34.00 | -- | MORGAN STANLEY | -- | -- | 02/09/2024 | |
| 2025 | 20.00 | 8.00 | -- | UBS | -- | -- | 01/11/2024 | |
| 2025 | -19.00 | -8.00 | -- | CITIC SEC | -- | -- | 04/11/2024 | |
| 2025 | -77.00 | -31.00 | -- | CICC | -- | -- | 31/08/2024 | |
| 2025 | -90.00 | -36.50 | -- | BANK OF AMERICA | -- | -- | 30/08/2024 | |
| 2026 | 251.00 | 102.00 | -- | MORGAN STANLEY | -- | -- | 02/09/2024 | |
| 2026 | 402.00 | 162.00 | -- | UBS | -- | -- | 01/11/2024 | |
| 2026 | 103.00 | 42.00 | -- | CITIC SEC | -- | -- | 04/11/2024 | |
| 2026 | 230.00 | 92.90 | -- | BANK OF AMERICA | -- | -- | 30/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 22/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -225,373,000 |
| %Change | -73.215% |
| EPS / (LPS) | RMB -0.910 |
| NBV Per Share (¥) | RMB 20.447 |